Invitation for 2026 Biomedical Pitch Competition
You are invited to the 2026 Biomedical Pitch Competition, connecting biomedical start-ups with investors and other business accelerator resources. Please submit your applications by Feb 28th, 2026. All biomedical startups from concept to pre-IPO are welcome to participate.
Benefits of Firms Participating in Pitch Competition?
-$300+ million raised from participant firms in the last four years
–Potential direct equity investment from 200+ Angel/VC funds/MNCs
-Many top-tier VCs & MNCs serve as final judges
–Fundraising, License Out or NewCo opportunities for your technology
-Partnership opportunities from venture capitalists, serial entrepreneurs, corporate executives, and attorneys
-Media exposure through partners’ networks. (20k+ views)
A Track Record of Impact
| 2025 Pitch Competition Highlights Epigenic raised $60 million successfully (https://bcicglobal.org/affinity_raised_fund/) Groovy raised funding (https://bcicglobal.org/groovy_secured_funding/) |
| 2024 Pitch Competition Highlights Rapafusyn raised $44 million successfully in USA (https://bcicglobal.org/rapafusyn_44mil/) Agilis secured $10 million successfully from a Singapore family office (https://bcicglobal.org/agilis_raised_10mill/) GV20 secured funding of over $30 million successfully (https://bcicglobal.org/dv20_secured_funding/) Affinity secured funding of $55 million（https://bcicglobal.org/affinity_raised_fund/） ImmViral filed for IPO(https://bcicglobal.org/immviral_file_ipo/) |
| 2023 Pitch Competition Highlights Myrobalan raised $24 million successfully in the US within 5 months after participating in the pitch competition. (https://bcicglobal.org/myrobalan-therapeutics-secures-funding-of-24-million/) Two startups raised $2mil and $2mil separately.At least one startup landed in Asia |
| 2022 Pitch Competition Highlights Amytrx has raised $18 million ARIZ Precision Medicine has raised $3 million Biostage has raised $5 millionAt least two startups landed in Asia |
Timeline:
The deadline for registration: Feb 28th, 2026
Preliminary Pitches: March, 2026
Semi Final Pitches：March, 2026
Final Contest: May, 2026
Please register by scanning the QR Code or using the link below
Option 1 (preferred): Google Form
https://forms.gle/uZbefcLhdNXQC2Ek8
Option 2 (for those who cannot use Google Form): JinshuJu Form
https://3nv6qhsf.jsjform.com/f/dFKDMv
Startups Requirements:
· Comply with the relevant laws, regulations, and policies of the United States and residing countries, and do not infringe on the intellectual property rights and other legal rights of others. Individuals, teams, and companies participating in the competition shall be responsible for the authenticity and accuracy of the registration information.
· The ideas or products submitted are innovative and original with certain social and market value.
· Startups must be in the biomedical industry or sub-industries.
· Specify the individual, company, or team in the application.
· No restriction on participants’ nationality. Any entities looking for Chinese-funded or US-funded are welcome to participate.
Judges (TBD)
· Hong Kong Science and Technology Parks Corporation (HKSTP)
· Chugai Venture Fund
· SOSV
· Northern Light Venture Capital
· Kendall Capital Partners (KCP)
· PagodaTree Partners
– Eisai Innovation Inc.
– TCG Crossover
· etc
Promotion Partners List
| · Harvard Life Lab · Harvard Innovation Labs · Harvard Wyss Institute · Harvard Medical School CSSA · Ohio State University College of Pharmacy Innovation Center · Pittsburg University Healthcare Incubator · Stanford University Healthcare Innovation Lab – Stanford Pipeline · Nest.Bio · Netherlands Innovation Center (NIC) · Frees Fund · JJLake Asia Future Innovation Challenger · Dane Capital · Aquillius · Simcere Therapeutical · Blue Ocean Capital Group · Chinese Entrepreneurs Organization at Duke (DukeCEO) · Penn Quakers Venture Club · Fish & Richardson · InnoStar · Porton · 闻药事 · Panacro USA | · Yale Venture Club · The Hopkins Club for Innovation and Entrepreneurship · Asia America Innovation Alliance (AAIA) · GeneOnline · Life-Science Entrepreneurship and Plus (LEAP) · Huazhong University of Science and Technology (HUST) Boston Alumni Association · Tongji Medical College of HUST Boston Chapter · YuanBio Venture Capital · AAEA · PagodaTree Partners · AbbVie Ventures · F Prime · Amgen Venture · TOP Innovation Districts Lab · Greenberg Traurig · Baker Mckenzie · The Chinese Antibody Society (CAS) · Berkley QB3 · Startup Boston · 博药 · 前途汇 · Bio-Link | · VIVA · Medicilon · ATLATL · Xingu Chuangfu · Alliance of Venture and Entrepreneurs Organization for Chinese Students Alumni at Harvard · Slush China · Danen Capital · Association d’Incubateur Franco-Chinois (AIFC) · Brandeis Impact · Chinese Entrepreneurs Organization · CuBio Innovation Center · HiMed · HuaSu Future · Eisai Innovation Inc · Regent Advisors · Enterprise Singapore · Massachusetts Biomedical Initiatives (MBI) · K2 Venture Partners · Singapore Economic Development Board (EDB) · Saudi Aribia NEOM Biotech Investment · P4 Precision Medicine Accelerator（UK） |
Co-organizers
| Name | Description |
| Boston Capital Investment Club (BCIC) | The Boston Capital Investment Club (BCIC) is a Massachusetts-registered non-profit organization serving nearly 10,000 professionals in finance, venture capital, and various technology industries. Beyond being a Boston-centered platform, the BCIC has grown to facilitate nationwide and international knowledge exchange across healthcare, finance, and related fields. Since 2022, the organization has hosted annual biomedical pitch competitions, empowering startups to secure over $300 million in collective funding.https://bcicglobal.org/ |
| Hong Kong Science and Technology Parks Corporation (HKSTP) | With a 20-year history of transforming lives through innovation, technology and entrepreneurship, Hong Kong Science and Technology Parks Corporation (HKSTP) has been propelling success for the most creative minds and innovators around the globe, accelerating ambitions and delivering positive impact from Hong Kong to the Greater Bay Area and the world. As an advocate for the innovative spirit, we strive to cultivate a diverse talent pool, connect research to innofacturing through “new industrialisation”, and create a well-established I&T ecosystem that bridges innovators with high-potential partners and investors for ideas to grow and thrive.https://www.hkstp.org/ |
Contact Us
Please send any questions via email: info@bcicglobal.org
Website: www.bcicglobal.org
WeChat Platform: bcicglobal
About BCIC:
Boston Capital Investment Club (BCIC), established in 2016 in Massachusetts, is a non-profit organization with nearly 10,000 professionals in finance, venture capital, and technology. Serving as a Boston-centered global platform, BCIC facilitates the exchange of ideas, knowledge, and insights in technology and investment. Key activities include pitch competitions, conferences, and seminars.
Biomedical Pitch Competition:
Established in 2022, the BCIC Annual Biomedical Pitch Competition is a high-impact event that has facilitated over $300 million in collective funding for top biotech startups. The competition is highly curated, selecting just 12 finalists from approximately 200 applicants to present to over 200+ VCs, MNCs, and angel investors. Major supporters include HKSTP, Roche Accelerator, Simcere Pharmaceutical, F-Prime, and the Harvard innovation ecosystem. The 2026 Final Pitch is scheduled for May.